Women's Health

A cohort of postmenopausal women from Finland had a bone mineral density decrease of about 10% during a follow-up period of 25 years, according to findings published in the Journal of Bone and Mineral Research.

Metformin did not improve outcomes for most patients with early breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

The addition of entinostat to exemestane improved PFS for patients with hormone receptor-positive, HER2-negative advanced breast cancer, according to randomized phase 3 study results presented at San Antonio Breast Cancer Symposium.

Patients with breast cancer who developed tamoxifen-associated uterine cancer had fewer phosphatidylinositol 3-kinase pathway mutations than those with de novo cases, according to results presented at San Antonio Breast Cancer Symposium.

The addition of palbociclib to adjuvant endocrine therapy did not extend invasive DFS for patients with early hormone receptor-positive, HER2-negative breast cancer, according to results presented at San Antonio Breast Cancer Symposium.

An exercise protocol that combined high-intensity interval training and intensive lower-extremity resistance training enhanced training response in women undergoing cardiac rehabilitation compared with standard exercise training.

Cytoreductive surgery before chemotherapy led to significant and clinically meaningful OS and PFS benefits for women with recurrent ovarian cancer, according to a phase 3 study published in The New England Journal of Medicine.

The FDA granted priority review to olaparib for adjuvant treatment of certain patients with high-risk breast cancer.

The FDA approved the imaging drug pafolacianine to help surgeons identify ovarian cancer lesions.

Postmenopausal women participating in 4 hours of standing plus 3 hours of walking per day had improved insulin sensitivity similar to those who engaged in 1 hour of moderate to vigorous exercise, according to study findings.